FR1 Notice

30076

Federal Register / Vol. 80, No. 100 / Tuesday, May 26, 2015 / Notices

A. Federal Reserve Bank of St. Louis
(Yvonne Sparks, Community
Development Officer) P.O. Box 442, St.
Louis, Missouri 63166–2034:
1. Pulaski Financial Corp., St. Louis,
Missouri; to become a bank holding
company through the conversion of its
wholly owned subsidiary, Pulaski Bank,
Creve Coeur, Missouri, from a federal
savings bank to a national association
charter.
In connection with this proposal,
Applicant also has applied to engage in
lending activities, pursuant to section
225.28(b)(2).
Board of Governors of the Federal Reserve
System, May 20, 2015.
Michael J. Lewandowski,
Associate Secretary of the Board.
[FR Doc. 2015–12625 Filed 5–22–15; 8:45 am]
BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention

mstockstill on DSK4VPTVN1PROD with NOTICES

Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 80 FR 1745–17459,
dated April 1, 2015) is amended to
reflect the reorganization of the Office of
Public Health Preparedness and
Response, Centers for Disease Control
and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete item (8) of the functional
statement for the Office of the Director
(CGE1), Division of Strategic National
Stockpile (CGE), Office of Public Health
Preparedness and Response (CG), and
renumber remaining items accordingly.
Delete in its entirety the mission
statement for the Division of State and
Local Readiness (CGC) and insert the
following:
Division of State and Local Readiness
(CGC): The Division of State and Local
Readiness provides program support,
technical assistance, guidance, technical
integration and capacity building of
preparedness planning across the public
health, healthcare, and emergency
management sectors and fiscal oversight
to state, local, tribal and territorial
public health department grantees for

VerDate Sep<11>2014

17:50 May 22, 2015

Jkt 235001

the development, monitoring and
evaluation of public health capabilities,
plans, infrastructure and systems to
prepare for and respond to terrorism,
outbreaks of disease, natural disasters
and other public health emergencies.
After the title and functional
statement for the Field Services Branch
(CGCD), Division of State and Local
Readiness (CGC), Office of Public Health
Preparedness and Response (CGA),
insert the following:
Public Health and Health Systems
Capacity Building Branch (CGCE). (1)
Facilitates the improvement of the
preparedness and response capabilities
of the nation’s public health and
healthcare system in collaboration with
Hospital Preparedness Program/
Assistant Secretary for Preparedness
and Response (HPP/ASPR) to strengthen
the intersect between public health,
healthcare systems, and emergency
management at the state and local level,
specifically, this branch strives to
improve medical countermeasure
planning at the state and local level; (2)
creates a system for assuring
coordination, collaboration, and
communication between HPP/ASPR and
the Division of State and Local
Readiness, CDC; (3) improves states and
local healthcare systems planning and
response through development of
guidance, tools, program monitoring,
technical assistance, and training; (4)
improves the delivery of technical
assistance to the public health and
healthcare sector; (5) serves as an agent
of information to improve awardee
access to healthcare preparedness tools
and expertise; (6) assures healthcare
system preparedness in the top 10
Urban Areas Security Initiative (UASI)
regions covered by executive order
13527; (7) facilitates the enhancement of
healthcare preparedness at the state/
local public health department level to
have a national impact; (8) provides
health communications guidance and
products before, during, and after an
event to assist state/local public health
departments and the healthcare systems
in developing risk communicating
strategies and messages; and (9)
collaborates with the Division of
Strategic National Stockpile, Response
and Logistics Branches during exercises
or upon a federal deployment of DSNS
assets.
James Seligman,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2015–12513 Filed 5–22–15; 8:45 am]
BILLING CODE 4160–18–P

PO 00000

Frm 00040

Fmt 4703

Sfmt 4703

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed Projects:
Title: Trafficking Victim Assistance
Program Data.
OMB No.: 0970—NEW.
Description: The Trafficking Victims
Protection Act of 2000 (TVPA), as
amended, authorizes the Secretary of
Health and Human Services to expand
benefits and services to foreign
nationals in the United States who are
victims of severe forms of trafficking in
persons. Such benefits and services may
include services to assist potential
victims of trafficking. (Section
107(b)(1)(B) of the TVPA, 22 U.S.C.
7105(b)(1)(B)).
ORR intends award cooperative
agreements in fiscal year 2015 to
approximately three organizations that
will ensure national coverage. The
awarded organization must provide
comprehensive case management and
referrals to qualified persons, either
directly through its own organization or
by partnering with other organizations
through contracts or both.
Persons qualified for services under
this grant are victims of a severe form
of trafficking in persons who have
received certification from ORR;
potential victims of a severe form of
trafficking who are actively seeking to
achieve ORR certification; and minor
dependent children of foreign victims of
severe forms of trafficking in persons or
potential victims of trafficking.
To help measure each grant project’s
performance and the success of the
program in assisting participants, and to
assist grantees to assess and improve
their projects over the course of the
project period, ORR proposes to collect
information from TVAP grant project
participants through the grantees on a
monthly, quarterly, or annual basis,
including participant demographics
(age, sex, and country of origin), type of
trafficking experienced (sex, labor, or
both), and immigration status during
participation.
This information will help ORR assess
the project’s performance in assisting
victims of trafficking and will better
enable TVAP grantees to meet the
program objectives and to monitor and
evaluate the quality of case management
services provided by any
subcontractors. ORR will also include
aggregate information in reports to
Congress to help inform strategies and

E:\FR\FM\26MYN1.SGM

26MYN1

30077

Federal Register / Vol. 80, No. 100 / Tuesday, May 26, 2015 / Notices
policies to assist victims of human
trafficking.

Respondents: Individual participants
in TVAP projects.

ANNUAL BURDEN ESTIMATES
Instrument

Number of
respondents

Number of
responses per
respondent

Average
burden hours
per response

Total burden
hours

Request for Information ...................................................................................

1250

1

.25

312.5

Estimated Total Annual Burden
Hours: 312.5.
In compliance with the requirements
of Section 506(c)(2)(A) of the Paperwork
Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Planning, Research
and Evaluation, 370 L’Enfant
Promenade SW., Washington, DC 20447,
Attn: ACF Reports Clearance Officer.
Email address: infocollection@
acf.hhs.gov. All requests should be
identified by the title of the information
collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2015–12591 Filed 5–22–15; 8:45 am]

mstockstill on DSK4VPTVN1PROD with NOTICES

BILLING CODE 4184–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–1819]

Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Spousal Influence
on Consumer Understanding of and
Response to Direct-to-Consumer
Prescription Drug Advertisements
AGENCY:

Food and Drug Administration,

HHS.
ACTION:

Notice.

The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by June 25,
2015.
SUMMARY:

To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–NEW and
title ‘‘Spousal Influence on Consumer
Understanding of and Response to
Direct-to-Consumer (DTC) Prescription
Drug Advertisements’’. Also include the
FDA docket number found in brackets
in the heading of this document.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
ADDRESSES:

In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.

SUPPLEMENTARY INFORMATION:

VerDate Sep<11>2014

17:50 May 22, 2015

Jkt 235001

PO 00000

Frm 00041

Fmt 4703

Sfmt 4703

Spousal Influence on Consumer
Understanding of and Response to
Direct-to-Consumer Prescription Drug
Advertisements—(OMB Control
Number 0910–NEW)
Section 1701(a)(4) of the Public
Health Service Act (42 U.S.C.
300u(a)(4)) authorizes FDA to conduct
research relating to health information.
Section 1003(d)(2)(C) of the Federal
Food, Drug, and Cosmetic Act (the
FD&C Act) (21 U.S.C. 393(d)(2)(C))
authorizes FDA to conduct research
relating to drugs and other FDA
regulated products in carrying out the
provisions of the FD&C Act.
Consumers are often thought of as
individual targets for prescription drug
advertisements (ads), as if they are
always exposed to DTC ads individually
and subsequently make judgments about
advertised products on their own.
However, judgments about prescription
drugs portrayed in DTC television ads
are likely made in social contexts much
of the time. For example, a potential
consumer and his or her spouse (e.g.,
marital or domestic partner) may view
an ad together and discuss drug
benefits, side effects, and risks. These
social interactions may result in unique
reactions relative to consumers who
view DTC prescription drug television
ads alone. For example, spouses may
influence their partner by expressing
concern about risks and side effects that
might occur, or pressuring their partner
to consider the drug despite its risks and
side effects. These outcomes have
important public health implications.
The Office of Prescription Drug
Promotion plans to examine differences
between consumers viewing
prescription drug ads with a spouse
versus alone through empirical research.
The main study will be preceded by
pretesting designed to delineate the
procedures and measures used in the
main study. Pretest and main study
participants will be couples who are
married or in a marital-like living
arrangement in which one member
(consumer) has asthma and the other
does not (spouse). All participants will
be 18 years of age or older and married
or cohabiting for 6 months or longer. We
will exclude individuals who work in

E:\FR\FM\26MYN1.SGM

26MYN1